Douglas Fambrough

Director/Board Member at

Anjarium Biosciences AG

57 year

88 connections

Health Technology

Consumer Services

Commercial Services

Profile

Douglas McIntosh Fambrough was the founder of Dicerna Pharmaceuticals, Inc., founded in 2007, where the title held was President, Chief Executive Officer & Director from 2010 to 2021.
Current jobs include Non-Executive Director at Anjarium Biosciences AG since 2022, Independent Director at Switch Therapeutics, Inc. since 2023, and Non-Executive Director at Sirius Therapeutics since 2022.
Former jobs include Director at Sirna Therapeutics, Inc. from 2003 to 2006, Director at Xencor, Inc., Solstice Neurosciences, Inc., Melinta Subsidiary Corp., and Solexa, Inc., Director at Oncorus, Inc. from 2022 to 2023, Independent Director at TScan Therapeutics, Inc. from 2020 to 2021, General Partner at Oxford Bioscience Partners from 1999 to 2010, and Trustee at The Boston Biomedical Research Institute.
Education includes a doctorate from the University of California, Berkeley in 1996 and an undergraduate degree from Cornell University in 1991.

Douglas Fambrough active positions

Companies	Position	Start
Anjarium Biosciences AG Anjarium Biosciences AG BiotechnologyHealth Technology Develops non-viral gene therapy	Director/Board Member	17/10/2022
Switch Therapeutics, Inc. Switch Therapeutics, Inc. BiotechnologyHealth Technology Develops RNAi research for therapeutic applications	Director/Board Member	09/07/2023

All active positions of Douglas Fambrough

Former positions of Douglas Fambrough

Companies	Position	End
ONCORUS, INC.	Director/Board Member	19/07/2023
DICERNA PHARMACEUTICALS, INC.	Founder	27/12/2021
TSCAN THERAPEUTICS, INC.	Director/Board Member	28/02/2021
Sirna Therapeutics, Inc. Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products	Director/Board Member	28/12/2006
Solexa, Inc. Solexa, Inc. Pharmaceuticals: OtherHealth Technology Creates DNA cloning and analyses technologies	Director/Board Member	27/08/2006

See the detail of Douglas Fambrough's experience

Training of Douglas Fambrough

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Douglas Fambrough's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Sirna Therapeutics, Inc. Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products	Commercial Services
Oxford Bioscience Partners Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations.	Finance
Xencor, Inc. Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions	Health Technology
Solstice Neurosciences, Inc. Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, sells and markets biopharmaceutical products	Health Technology
Dicerna Pharmaceuticals, Inc. Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases	Health Technology
Cornell University Cornell University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Melinta Subsidiary Corp. Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections	Health Technology
Solexa, Inc. Solexa, Inc. Pharmaceuticals: OtherHealth Technology Creates DNA cloning and analyses technologies	Health Technology
The Boston Biomedical Research Institute
Oncorus, Inc. Oncorus, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops next generation immunotherapy platform to treat cancer	Health Technology
TScan Therapeutics, Inc. TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients	Health Technology
Anjarium Biosciences AG Anjarium Biosciences AG BiotechnologyHealth Technology Develops non-viral gene therapy	Health Technology
Switch Therapeutics, Inc. Switch Therapeutics, Inc. BiotechnologyHealth Technology Develops RNAi research for therapeutic applications	Health Technology